Clinical Trial Update: Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin [Phase 2]

View source ↗

Summary

Phase 2 trial updating chemoradiotherapy with raltitrexed-cisplatin for locally advanced nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Raltitrexed-cisplatin

Snippet

Sponsor: Hubei Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED